Results 71 to 80 of about 1,090 (156)
Sight-Threatening Condition in Severe Thyroid Eye Disease: How We Should Manage
Acta Medica Indonesiana, 2022 Thyroid eye disease (TED) is an autoimmune disorder that is associated with thyroid gland dysfunction which causes muscle and orbital fat enlargement.
Yunia Irawati +5 more
doaj
, 2023 This is the raw data from 44 patients with Grave's disease. The parameters included in this raw data are: id, age, sex, smoking, ft4ngd_l, tr_ab_iul, dm, ht, family_history, cas, eugogo, dermopathy, duration of diagnosis in months, status of go, hmgb1 ...
Dhite Nugroho (14642171)
core +1 more source
Oftalmopatía de Graves. Diagnóstico, evaluación y tratamiento
Revista Mexicana de Endocrinología, Metabolismo y NutriciónLa oftalmopatía u orbitopatía de Graves (OG) es un trastorno autoinmune e inflamatorio (prevalencia 30 a 50% en enfermedad de Graves), caracterizada por inflamación de los tejidos orbitarios y protrusión ocular, debido a involucro de las células Th1 y ...
Fernando Bolaños-Gil de Montes +1 more
doaj +1 more source
Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy
Türk Oftalmoloji Dergisi, 2015 Objectives: To discuss our follow-up and treatment results in thyroid-associated ophthalmopathy (TAO). Materials and Methods: The records of 168 TAO cases who were followed at our clinic between October 1998 and October 2013 were reviewed ...
Esra Savku, Kaan Gündüz
doaj +1 more source
Thyroid Eye Disease: Current Perspectives in Pathogenesis, Risk Factors, and Management
TNOA Journal of Ophthalmic Science and ResearchThyroid eye disease (TED), also referred to as Graves’ orbitopathy or thyroid-associated ophthalmopathy, is an autoimmune inflammatory disorder of the orbit that most often accompanies hyperthyroidism due to Graves’ disease.
Pratheeba Devi Nivean +3 more
doaj +1 more source
Acta Ophthalmologica, Volume 102, Issue S283, Page 3-25, September 2024.
Lena Boulakh
wiley +1 more source
Photodiagnosis and Photodynamic TherapyPurpose: This study aimed to develop a clinically accessible, cost-effective nomogram model to predict intravenous glucocorticoid (IVGC) response in active moderate-to-severe thyroid-associated ophthalmopathy (TAO) by integrating novel optical coherence ...
Yinru Wang +5 more
doaj +1 more source
The Relationship of Thyroid Stimulating Hormone Receptor Antibody (TRAb) Levels to Activity and Clinical Severity of Graves' Ophthalmopathy in RSUP Dr. Sardjito [PDF]
Background: Graves' disease (GD) is an autoimmune disease that is the most common cause of hyperthyroidism. Thyroid stimulating hormone receptor antibody (TRAb) is a specific biomarker for diagnosing GD.
Susanti, Vina Yanti +2 more
core +1 more source
Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves’ Orbitopathy [PDF]
European Journal of Endocrinology, 2021 openaire +2 more sources
Thyrotropin Receptor Antibody as a Risk Factor for the Occurrence and Severity of Graves' Ophthalmopathy [PDF]
Background. Graves' disease (GD) is an autoimmune disorder known to be the most common cause of hyperthyroidism. Thyrotropin receptor antibody (TRAb) might be involved in the occurrence and the disease process of Graves’ ophthalmopathy (GO).Objectives ...
Rianto, Bambang Udji Djoko +3 more
core +1 more source